Beyond Medical Technologies Inc.
DOCT
CNSX
| Weiss Ratings | DOCT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | DOCT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DOCT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.81 | |||
| Price History | DOCT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 33.33% | |||
| 30-Day Total Return | 966.67% | |||
| 60-Day Total Return | 433.33% | |||
| 90-Day Total Return | 433.33% | |||
| Year to Date Total Return | 357.14% | |||
| 1-Year Total Return | 433.33% | |||
| 2-Year Total Return | 146.15% | |||
| 3-Year Total Return | -64.44% | |||
| 5-Year Total Return | -80.00% | |||
| 52-Week High % Change | -50.00% | |||
| 52-Week Low % Change | 533.33% | |||
| Price | DOCT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.19 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Jan 15, 2025 | |||
| 52-Week High Price (Date) | Feb 25, 2025 | |||
| Valuation | DOCT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 553.98K | |||
| Enterprise Value | 576.30K | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.04 | |||
| Earnings Per Share Growth | -49.38% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -1.89 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.16 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -1.65 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | DOCT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 7.91M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | DOCT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 604-805-4602 | |||
| Address | 1055 West Georgia Street Vancouver, BC V6E 4N7 | |||
| Website | www.beyond-md.ca | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | DOCT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | DOCT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -378.24% | |||
| Return on Equity | -- | |||
| Income Statement | DOCT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -350.10K | |||
| Net Income (TTM) | -293.50K | |||
| Net Income Avl. to Common (TTM) | -293.50K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 3.66% | |||
| EPS Diluted (TTM) | -0.04 | |||
| EPS Diluted Growth (Q YOY) | 1.06% | |||
| Balance Sheet | DOCT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 22.10K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 23.60K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -396.90K | |||
| Current Ratio (Q) | 0.056 | |||
| Book Value Per Share (Q) | -$0.05 | |||
| Total Assets (Q) | 23.60K | |||
| Total Current Liabilities (Q) | 420.50K | |||
| Total Debt (Q) | 44.40K | |||
| Total Liabilities (Q) | 420.50K | |||
| Total Common Equity (Q) | -396.90K | |||
| Cash Flow | DOCT - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 44.40K | |||
| Net Change in Cash (TTM) | -23.30K | |||
| Levered Free Cash Flow (TTM) | 27.90K | |||
| Cash from Operations (TTM) | -85.60K | |||
